Janet M. Beanan

2.3k total citations
25 papers, 1.8k citations indexed

About

Janet M. Beanan is a scholar working on Molecular Medicine, Endocrinology and Infectious Diseases. According to data from OpenAlex, Janet M. Beanan has authored 25 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Medicine, 13 papers in Endocrinology and 7 papers in Infectious Diseases. Recurrent topics in Janet M. Beanan's work include Antibiotic Resistance in Bacteria (21 papers), Escherichia coli research studies (8 papers) and Bacterial Genetics and Biotechnology (7 papers). Janet M. Beanan is often cited by papers focused on Antibiotic Resistance in Bacteria (21 papers), Escherichia coli research studies (8 papers) and Bacterial Genetics and Biotechnology (7 papers). Janet M. Beanan collaborates with scholars based in United States, Canada and India. Janet M. Beanan's co-authors include Thomas A. Russo, Ruth Olson, Ulrike MacDonald, Timothy C. Umland, Anthony A. Campagnari, Bruce A. Davidson, Nicole R. Luke, L. Wayne Schultz, Catherine McFadden and Yoav Keynan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

Janet M. Beanan

25 papers receiving 1.8k citations

Peers

Janet M. Beanan
Ruth Olson United States
Ulrike MacDonald United States
Yoo Chul Lee South Korea
Sujay Chattopadhyay United States
Sung Yong Seol South Korea
Dong Taek Cho South Korea
Ruth Olson United States
Janet M. Beanan
Citations per year, relative to Janet M. Beanan Janet M. Beanan (= 1×) peers Ruth Olson

Countries citing papers authored by Janet M. Beanan

Since Specialization
Citations

This map shows the geographic impact of Janet M. Beanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet M. Beanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet M. Beanan more than expected).

Fields of papers citing papers by Janet M. Beanan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet M. Beanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet M. Beanan. The network helps show where Janet M. Beanan may publish in the future.

Co-authorship network of co-authors of Janet M. Beanan

This figure shows the co-authorship network connecting the top 25 collaborators of Janet M. Beanan. A scholar is included among the top collaborators of Janet M. Beanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet M. Beanan. Janet M. Beanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Russo, Thomas A., Timothy C. Umland, Xiaoyi Deng, et al.. (2022). Repurposed dihydroorotate dehydrogenase inhibitors with efficacy against drug-resistant Acinetobacter baumannii. Proceedings of the National Academy of Sciences. 119(51). e2213116119–e2213116119. 8 indexed citations
2.
Lin, Shun Xin Wang, Ruth Olson, Janet M. Beanan, et al.. (2019). Antibody Dependent Enhancement of Acinetobacter baumannii Infection in a Mouse Pneumonia Model. Journal of Pharmacology and Experimental Therapeutics. 368(3). 475–489. 17 indexed citations
4.
Russo, Thomas A., et al.. (2016). The Response Regulator BfmR Is a Potential Drug Target for Acinetobacter baumannii. mSphere. 1(3). 75 indexed citations
5.
MacDonald, Ulrike, Janet M. Beanan, Ruth Olson, et al.. (2015). Structure of shikimate kinase, anin vivoessential metabolic enzyme in the nosocomial pathogenAcinetobacter baumannii, in complex with shikimate. Acta Crystallographica Section D Biological Crystallography. 71(8). 1736–1744. 7 indexed citations
6.
Russo, Thomas A., Ruth Olson, Ulrike MacDonald, Janet M. Beanan, & Bruce A. Davidson. (2015). Aerobactin, but Not Yersiniabactin, Salmochelin, or Enterobactin, Enables the Growth/Survival of Hypervirulent (Hypermucoviscous) Klebsiella pneumoniae Ex Vivo and In Vivo. Infection and Immunity. 83(8). 3325–3333. 219 indexed citations
7.
Umland, Timothy C., L. Wayne Schultz, Ulrike MacDonald, et al.. (2012). In Vivo -Validated Essential Genes Identified in Acinetobacter baumannii by Using Human Ascites Overlap Poorly with Essential Genes Detected on Laboratory Media. mBio. 3(4). 70 indexed citations
8.
Kong, Qingli, Janet M. Beanan, Ruth Olson, et al.. (2012). Biofilm formed by a hypervirulent (hypermucoviscous) variant of Klebsiella pneumoniae does not enhance serum resistance or survival in an in vivo abscess model. Virulence. 3(3). 309–318. 17 indexed citations
10.
Beanan, Janet M., et al.. (2011). Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumonia: an emerging and under-recognized pathogenic variant. European Journal of Clinical Microbiology & Infectious Diseases. 31(6). 981–989. 174 indexed citations
11.
Russo, Thomas A., Malcolm G. P. Page, Janet M. Beanan, et al.. (2011). In vivo and in vitro activity of the siderophore monosulfactam BAL30072 against Acinetobacter baumannii. Journal of Antimicrobial Chemotherapy. 66(4). 867–873. 51 indexed citations
12.
Russo, Thomas A., Nicole R. Luke, Janet M. Beanan, et al.. (2010). The K1 Capsular Polysaccharide of Acinetobacter baumannii Strain 307-0294 Is a Major Virulence Factor. Infection and Immunity. 78(9). 3993–4000. 272 indexed citations
13.
Luke, Nicole R., Thomas A. Russo, Janet M. Beanan, et al.. (2010). Identification and Characterization of a Glycosyltransferase Involved in Acinetobacter baumannii Lipopolysaccharide Core Biosynthesis. Infection and Immunity. 78(5). 2017–2023. 93 indexed citations
14.
Russo, Thomas A., Ulrike MacDonald, Janet M. Beanan, et al.. (2009). Penicillin‐Binding Protein 7/8 Contributes to the Survival ofAcinetobacter baumanniiIn Vitro and In Vivo. The Journal of Infectious Diseases. 199(4). 513–521. 83 indexed citations
15.
Russo, Thomas A., Janet M. Beanan, Ruth Olson, Ulrike MacDonald, & John J. Cope. (2008). Capsular polysaccharide and the O-specific antigen impede antibody binding: A potential obstacle for the successful development of an extraintestinal pathogenic Escherichia coli vaccine. Vaccine. 27(3). 388–395. 18 indexed citations
16.
Russo, Thomas A., Janet M. Beanan, Ruth Olson, et al.. (2008). Rat Pneumonia and Soft-Tissue Infection Models for the Study of Acinetobacter baumannii Biology. Infection and Immunity. 76(8). 3577–3586. 54 indexed citations
17.
Russo, Thomas A., Zhengdong Wang, Bruce A. Davidson, et al.. (2007). Surfactant dysfunction and lung injury due to theE. colivirulence factor hemolysin in a rat pneumonia model. American Journal of Physiology-Lung Cellular and Molecular Physiology. 292(3). L632–L643. 19 indexed citations
18.
Russo, Thomas A., Janet M. Beanan, Ruth Olson, et al.. (2007). A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate. Vaccine. 25(19). 3859–3870. 27 indexed citations
19.
Russo, Thomas A., Bruce A. Davidson, Janet M. Beanan, et al.. (2007). CAPSULE AND O-ANTIGEN FROM AN EXTRAINTESTINAL ISOLATE OFESHERICHIA COLIMODULATE CYTOKINE LEVELS IN RAT MACROPHAGES IN VITRO AND IN A RAT MODEL OF PNEUMONIA. Experimental Lung Research. 33(7). 337–356. 2 indexed citations
20.
Russo, Thomas A., Bruce A. Davidson, Natalie M. Warholic, et al.. (2005). E. colivirulence factor hemolysin induces neutrophil apoptosis and necrosis/lysis in vitro and necrosis/lysis and lung injury in a rat pneumonia model. American Journal of Physiology-Lung Cellular and Molecular Physiology. 289(2). L207–L216. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026